Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FEZLM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,255
Award facts
- Contract value 100% obligated
- $25,255.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,255.24 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen auto-injectors on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract involves delivery of pharmaceutical products to support federal medical procurement needs. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's extensive contract portfolio with DLA demonstrates its capability to fulfill complex federal pharmaceutical supply requirements across multiple therapeutic domains, from specialty medications to vaccines and medical devices. This delivery order for Cosentyx, a biologic immunosuppressant used for autoimmune conditions, reflects the company's ongoing role in supporting military medical readiness and healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FEZLM?
SPE2DB25FEZLM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FEZLM worth?
The government has obligated $25,255 on SPE2DB25FEZLM.
Is contract SPE2DB25FEZLM an order under another contract?
Yes. SPE2DB25FEZLM is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FEZLM competed?
The extent of competition for SPE2DB25FEZLM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award